ERBB2 amplifications in esophageal adenocarcinoma

Annals of Thoracic Surgery

Volumn 78, Issue 5, 2004, Pages 1790-1800

  Dahlberg, Peter S ^a,d   Jacobson, Blake A ^b   Dahal, Ganesh ^a   Fink, James M ^a   Kratzke, Robert A ^b   Maddaus, Michael A ^a   Ferrin, Lance J ^c  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Yakima Gastroenterology   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA; GROWTH FACTOR RECEPTOR BOUND PROTEIN 7; MESSENGER RNA; PROTEIN; RECA PROTEIN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ADENOCARCINOMA; AMPLICON; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CELL GROWTH; CHROMOSOME 14; CHROMOSOME 17; CHROMOSOME ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOGENETICS; DNA MICROARRAY; DRUG SENSITIVITY; ESOPHAGUS CANCER; EXPERIMENT; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MEASUREMENT; METASTASIS; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; RESTRICTION MAPPING; SOUTHERN BLOTTING; STAINING; STRUCTURE ANALYSIS; TANDEM REPEAT; TUMOR;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; BLOTTING, SOUTHERN; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 17; COMPUTER SYSTEMS; ESOPHAGEAL NEOPLASMS; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTO-ONCOGENES; RECEPTOR, ERBB-2; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS;

EID: 19644373932     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.05.037     Document Type: Article

References (35)

1. Devesa S.S., Blot W.J., Fraumeni J. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049-2053
2. Chen X., Yand C.S. Esophageal adenocarcinoma a review and perspective on the mechanisms of carcinogenesis and chemoprevention. Carcinogenesis. 22:2001;1119-1129
3. Hardwick R.H., Shepherd N.A., Moorghen M., Newcomb P.V., Alderson D. c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's esophagus. J Clin Pathol. 48:1995;129-132
4. Ross J.S., McKenna B.J. The HER-2/neu oncogenes in tumors of the gastrointestinal tract. Cancer Invest. 19:2001;554-568
5. http://www.biotech.ist.unige.it/cldb/cl3761.html
6. http://www.biotech.ist.unige.it/cldb/cl3762.html
7. Sambrook J., Rossell D.W., Sambrook J. Molecular cloning: a laboratory manual. 3rd ed :2001;Cold Spring Harbor Laboratory, Plainview, NY
8. Fienberg A.P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 132:1983;6-13
9. Ginzinger D.G., Godfrey T.E., Nigro J., et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res. 60:2000;5405-5409
10. Nigro J.M., Takahashi M.A., Ginzinger D.G., et al. Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol. 158:2001;1253-1262
11. Barch M., Knutsen T., Spurbeck J. The AGT cytogenetics laboratory manual, 3rd ed. 1977;Lippincott-Raven, Philadelphia, PA
12. Ferrin L.J., Camerini-Otero R.D. Selective cleavage of human DNA RecA-assisted restriction endonuclease (RARE) cleavage. Science. 254:1991;1494-1497
13. Wang Y., Schwaltz D.C. Chopped inserts a convenient alternative to agarose/DNA inserts or beads. Nucleic Acid Res. 21:1993;2528
14. Ferrin L.J., Camerini-Otero R.D. Long-range mapping of gaps and telomeres with RecA-assisted restriction endonuclease (RARE) cleavage. Nature Genet. 6:1994;379-383
15. Ferrin L.J. Flexible genetic engineering using RecA protein. Mol Biotechnol. 18:2001;233-241
16. Wolff R., Gemmill R. Purifying and analyzing genomic DNA. Green E.D., Birren B., Klapholz S., Myers R.M., Hieter P. Genome analysis a laboratory manual. 1997;186-207 Cold Spring Harbor Laboratory Press, Plainville, NY
17. Harlow E., Lane D. Antibodies: a laboratory manual. 1988;Cold Spring Harbor Laboratory, Cold Spring, NY
18. Miller C.T., Moy J.R., Lin L., et al. Gene amplification in esophageal adenocarcinomas and Barrett's with high dysplasia. Clin Cancer Res. 9:2003;4819-4825
19. Mendrola J.M., Berger M.B., King M.C., Lemmon M.A. The single transmembrane domains of ErbB receptors self-associate in cell membranes. J Biol Chem. 277:2002;4704-4712
20. Penuel E., Akita R.W., Sliwkowski M.X. Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association. J Biol Chem. 277:2002;28468-28473
21. kp1 and cyclin D1 through signaling pathways. Cancer Res. 61:2001;6583-6591
22. HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci USA. 84:1987;7159-7163
23. di Fiore P.P., Pierce J.H., Kraus M.H., Segatto O., King C.R., Aaronson S.A. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 237:1987;178-182
24. Skacel M., Ormsby A.H., Pettay J.D., et al. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray. Hum Pathol. 32:2001;1392-1397
25. Park J., Rhim J.S., Park S., Kimm S., Kraus M.H. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res. 49:1989;6605-6609
26. Chiang P., Beer D.G., Wei W., Orringer M.B., Kurnit D.M. Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients. Clin Cancer Res. 5:1999;1381-1386
27. Safran H., Steinhoff M., Mangray S., et al. Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma. Am J Clin Oncol. 24:2001;496-499
28. Hirsch F.R., Franklin W.A., Veve R., Varella-Garcia M., Bunn P.A. Jr. HER2/neu expression in malignant lung tumors. Semin Oncol. 29:2002;51-58
29. Seki A., Yoshinouchi M., Seki N., Kodama J., Miyagi Y., Kudo T. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer. Int J Oncol. 17:2000;103-106
30. Kauraniemi P., Kuukasjarvi T., Sauter G., et al. Amplification of a 280-kilobase core region of the ERBB2 locus leads to activation of 2 hypothetical proteins in breast cancer. Am J Path. 163:2003;1979-1984
31. Nezu M., Sasaki H., Kuwahara Y., et al. Identification of a novel promoter and exons of the cERBB-2 gene. Biochem Biophys Res Commun. 258:1999;499-505
32. Kauraniemi P., Barlund M., Monni O., Kallioniemi A. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res. 61:2001;8235-8240
33. Van De Vijver M.J., He Y.D., Van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 347:2002;1999-2009
34. Dahlberg P.S., Ferrin L.J., Grindle S.M., et al. Gene expression profiles in esophageal adenocarcinoma. Ann Thorac Surg. 77:2004;1008-1015
35. Berticci F., Borie N., Ginestier C., et al. Identification and validation of an ERBB2 gene expression signature in breast cancers. Oncogene. 23:2004;2564-2575